New Findings Reported from King Saud University Describe Advances in Breast Cancer (Development and Comparative Evaluation of Two Different Label-Free and Sensitive Fluorescence Platforms for Analysis of Olaparib: A Recently FDA-Approved Drug ...)

Press/Media

Period28 Sep 2023

Media coverage

1

Media coverage

  • TitleNew Findings Reported from King Saud University Describe Advances in Breast Cancer (Development and Comparative Evaluation of Two Different Label-Free and Sensitive Fluorescence Platforms for Analysis of Olaparib: A Recently FDA-Approved Drug ...)
    Media name/outletCDC & FDA Daily
    Country/TerritoryUnited States
    Date28/09/23
    PersonsNasr Khalil